Fish & Richardson P.C.
Preparation of and formulation comprising a MEK inhibitor
The present invention relates to processes for preparing 6-(4-bromo-2-fluorophenylamino)-7-fluoro-3-methyl-3H-benzoimidazole-5-carboxylic acid (2-hydroxyethyoxy)-amide, processes for preparing crystallized 6-(4-bromo-2-fluorophenylamino)-7-fluoro-3-methyl-3H-benzoimidazole-5-carboxylic acid (2-hydroxyethyoxy)-amide, and intermediates useful therefore. Also provided herein are pharmaceutical compositions comprising this crystallized compound.
Array BioPharma, Inc. Novartis AG
A C A C C A A A A C A A A A A A A A A C A
A61K C30B A61K C07D C30B A61K A61P A61P A61K C07D A61K A61K A61P A61K A61K A61K A61P A61P A61K C07B A61K
inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional additional inventional
Daniel Marie-Christine Marian Paul Daniel Andreas Peter J. Werner Heinz Christoph Max Weidong
Zimmermann Wolf Misun Nichols Niederer Stengel Pachinger Krell Liu